ALS Research Specialist (Consultant) @ Target ALS (January 2013 - April 2014)
Chief Scientific Officer @ (January 2008 - March 2014)
Chief Operating Officer @ (June 2007 - September 2010)
Program Officer @ JGPerpich, LLC (January 2005 - April 2007)
Program Director @ (January 2004 - January 2005)
Director, Department of Educational Programs @ (January 2003 - January 2004)
AAAS Science Policy Fellow @ US Senate Office and USAID (January 2001 - January 2003)
Melanie Leitner Education
Washington University School of Medicine in St. Louis
PhD (Neuroscience)
1994-2000
Washington University in St. Louis
PhD (Neuroscience)
1994-2000
Brown University
Sc.B. (Neural Sciences)
1989-1993
Melanie Leitner Skills
Neuroscience
Science
Research
Biotechnology
Life Sciences
Nonprofits
Grant Writing
Policy
R&D
Leadership
Program Management
Grants
Genetics
Strategy
Data Analysis
Clinical Research
Genomics
Management
Drug Development
Open Innovation
Mental Health
Science Policy
Biomarkers
Biomarker Discovery
ALS
Orphan Drug Development
Rare Disease
Clinical Development
Clinical Trials
Drug Discovery
Public Speaking
Start-ups
Project Management
Public Policy
Translational Medicine
Start Ups
Rare Diseases
Melanie Leitner Summary
Melanie Leitner, based in Boston, MA, US, is currently a Chief Scientific Officer at ALS Investment Fund. Melanie Leitner brings experience from previous roles at Carney Institute for Brain Science at Brown University, Accelerating NeuroVentures, LLC, Biogen and Target ALS. Melanie Leitner holds a 1994 - 2000 PhD in Neuroscience @ Washington University School of Medicine in St. Louis. With a robust skill set that includes Neuroscience, Science, Research, Biotechnology, Life Sciences and more. Melanie Leitner has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Melanie Leitner?
Find contact details for 700 million professionals.